Genetic Sensorineural Hearing Loss 

  • Author: Stephanie A Moody Antonio, MD; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Jun 1, 2009
 

Background

Of the more than 4000 infants born deaf each year, more than half have a hereditary disorder. Hereditary disorders must be differentiated from acquired hearing losses. Not all hereditary hearing loss is present at birth; some children inherit the tendency to develop hearing loss later in life.

Genetic sensorineural hearing loss (SNHL) includes a broad range of disorders that affect infants, children, and adults. Affected individuals may have unilateral or bilateral hearing loss ranging from mild to profound. This article, like most related discussions, focuses on childhood hearing loss, with consideration of a few forms of adult-onset hearing loss.

Next

Pathophysiology

Volumes of texts and journals are dedicated to the pathophysiology of genetic hearing loss and can not be easily summarized in a few paragraphs. Interestingly, note that as our understanding of the molecular basis of genetic hearing loss increases, so does our understanding of the molecular basis of hearing itself, although it remains still largely unsolved.[1, 2]

First, we must understand that genetic hearing loss seems to breach all categories of hearing loss, including the following: congenital, progressive, and adult onset; conductive, sensory, and neural; syndromic and nonsyndromic; high-frequency, low-frequency, or mixed frequency; and mild or profound. Genetic hearing loss may show patterns of recessive, dominant, or sex-linked inheritance and may be a result in mutation of both cellular or mitochondrial DNA (and RNA, in the case of mitochondrial genes). Genetic hearing loss may be subject to environment and aging, such as noise-induced or age-induced hearing loss.

New genetic mutations are linked to hearing loss every year. More than 100 loci have been identified involving genes that code for proteins involved in the structure and function of hair cells, supporting cells, spiral ligament, stria vascularis, basilar membrane, spiral ganglion cells, auditory nerve, and virtually every structural element of the inner ear.[3]

Inner ear. Inner ear.

Dysfunctional proteins have been identified in the impaired molecular-physiologic processes of potassium and calcium homeostasis,[4] apoptotic signaling,[5] stereocilia linkage,[6] mechanicoelectric transduction, electromotility, and other processes.[1] Eisen and Ryugo provide an excellent review of the molecular pathophysiology of genetic hearing loss.[1]

Previous
Next

Epidemiology

Frequency

United States

According to the National Institute on Deafness and Other Communication Disorders (NIDCD), hearing loss affects approximately 28 million Americans and approximately 17 in 1000 children and adolescents younger than 18 years. The average incidence of hearing loss in neonates in the United States is 1.1 per 1000 with variability among states ranging between 0.22 and 3.61 according to Mehra et al.[7] In the study by Mehra et al, the prevalence of childhood and adolescent hearing loss was 3.1%, with higher rates in Hispanic Americans and in families with lower incomes.[7]

Congenital hereditary hearing loss must be differentiated from acquired hearing loss. More than half of all cases of prelingual deafness are genetic. The remaining 40-50% of all cases of congenital hearing loss are due to nongenetic effects, such as prematurity, postnatal infections, ototoxic drugs, or maternal infection (with cytomegalovirus [CMV] or rubella). Most cases of genetic hearing loss are autosomal recessive and nonsyndromic. Hearing loss that results from abnormalities in connexin 26 and connexin 30 proteins likely account for 50% of cases of autosomal recessive nonsyndromic deafness in American children.

The incidence of hearing loss increases with age. Loss affects 314 in 1000 people older than 65 years and 40-50% of people aged 75 years or older. Adult-onset hearing loss can be attributed to normal aging processes and environmental triggers. However, an individual's genetic predisposition should not be underestimated, as illustrated by aminoglycoside-induced ototoxicity and the predisposition to noise-induced hearing loss.

Current statistics can be found on the Early Hearing Detection & Intervention (EHDI) Program Web site published by the Centers for Disease Control and Prevention.

International

Genetic sensorineural hearing loss (SNHL) appears to occur twice as often in developed countries as in underdeveloped countries. Hearing impairment affects up to 30% of the international community, and estimates indicate that 70 million persons are deaf. In addition to ancestry and race, the proportions of hereditary versus acquired and syndromic versus nonsyndromic hearing losses across populations is highly variable and is heavily influenced by multiple factors, some likely not yet identified, including drift of populations, frequency of consanguinity, and health status.

Estimating the prevalence of hereditary hearing loss in populations across the world is very difficult because access to health care, poor health conditions, and a low level of awareness of hearing loss is compounded by a higher frequency of complicating risk factors such as neonatal distress, prematurity, high fever, otitis media, meningitis, ototoxic medications, and illnesses such as rubella.[8]

An estimated 30,000 infants are born with sensorineural hearing loss each year in China, which has a population of about 1.3 billion, but the percentage of these hearing losses attributable to heredity is not known.[9] Saunders et al demonstrated a prevalence of significant hearing loss of 18% in a group of school-aged children in rural Nicaragua with a familial history of hearing loss in 24% of the children with hearing loss . [8] Large-scale epidemiologic studies are needed and will become more feasible as molecular testing is made available to the world’s populations.

Mortality/Morbidity

The 350,000 individuals who are profoundly deaf in the United States earn approximately 30% less than the general population. Among school-aged children with hearing loss, approximately 52,000 attend schools or programs for the deaf, 100,000 are enrolled in special deaf-education classes, and 250,000 participate in standard public school settings. The overall cost for deafness education is estimated to be $121 billion.

Race

Genetic hearing loss does have significant ethnic links. Angeli recently reviewed the ethnic variability of DGNB1 and showed greater allelic variability in Hispanics.[10] Schimmenti et al showed a lower prevalence of connexin-related hearing loss in Hispanic infants.[11]

Age

Before universal hearing screening for newborns, less than 50% of children who had hearing impairment were identified before the age of 3 years. Detection of risk factors (eg, prematurity, low birth weight, low Apgar scores) helps in identify less than 50% of infants who have or who are at risk for hearing loss. In one study, 78% of infants identified with hearing loss were in the well-baby nursery and not the neonatal intensive care nursery.[12] This finding emphasized the ineffectiveness of screening on the basis of risk identification alone. Thirty-six states now mandate universal screening of newborns resulting in earlier identification and treatment. Hereditary hearing loss may also be progressive or adult in onset.

Previous
Proceed to Clinical Presentation
 
 
Contributor Information and Disclosures
Author

Stephanie A Moody Antonio, MD  Assistant Professor, Department of Otolaryngology-Head and Neck Surgery, Eastern Virginia Medical School

Stephanie A Moody Antonio, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, and Virginia Society of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Coauthor(s)

Barry Strasnick, MD, FACS  Chairman, Professor, Department of Otolaryngology - Head and Neck Surgery, Eastern Virginia Medical School

Barry Strasnick, MD, FACS is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Auditory Society, American College of Surgeons, American Medical Association, American Tinnitus Association, Ear Foundation Alumni Society, Norfolk Academy of Medicine, North American Skull Base Society, Society of University Otolaryngologists-Head and Neck Surgeons, Vestibular Disorders Association, and Virginia Society of Otolaryngology-Head and Neck Surgery

Disclosure: Nothing to disclose.

Specialty Editor Board

Robert A Battista, MD, FACS  Assistant Professor of Otolaryngology, Northwestern University Medical School; Physician, Ear Institute of Chicago, LLC

Robert A Battista, MD, FACS is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, and Illinois State Medical Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Gerard J Gianoli, MD  Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Karen K Hoffmann, MD, to the development and writing of this article.

References

  1. Eisen MD, Ryugo DK. Hearing molecules: contributions from genetic deafness. Cell Mol Life Sci. Mar 2007;64(5):566-80. [Medline]. [Full Text].

  2. Vrijens K, Van Laer L, Van Camp G. Human hereditary hearing impairment: mouse models can help to solve the puzzle. Hum Genet. Nov 2008;124(4):325-48. [Medline].

  3. Van Camp G, SmithR. Cloned genes for nonsyndromic hearing impairment. Hereditary Hearing Loss Homepage. Available at http://hereditaryhearingloss.org/. Accessed 04/14/09.

  4. Brini M, Di Leva F, Domi T, Fedrizzi L, Lim D, Carafoli E. Plasma-membrane calcium pumps and hereditary deafness. Biochem Soc Trans. Nov 2007;35 (pt 5):913-8.

  5. Xing G, Chen Z, Cao X. Mitochondrial rRNA and tRNA and hearing function. Cell Res. Mar 2007;17(3):227-39. [Medline]. [Full Text].

  6. El-Amraoui A, Petit C. Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells. j cell sci. 2005/10;118(Pt 20):4593-603. [Full Text].

  7. Mehra S, Eavey RD, Keamy DG Jr. The epidemiology of hearing impairment in the United States: newborns, children, and adolescents. Otolaryngol Head Neck Surg. Apr 2009;140(4):461-72. [Medline].

  8. Saunders JE, Vaz S, Greinwald JH, Lai J, Morin L, Mojica K. Prevalence and etiology of hearing loss in rural Nicaraguan children. Laryngoscope. Mar 2007;117(3):387-98. [Medline].

  9. Ouyang XM, Yan D, Yuan HJ, et al. The genetic basis of non-syndromic hearing loss among Chinese. J Hum Genet. 2009;54(3):131-40.

  10. Angeli SI. Phenotype/genotype correlations in a DFNB1 cohort with ethnical diversity. Laryngoscope. Nov 2008;118(11):2014-23. [Medline].

  11. Schimmenti LA, Martinez A, Telatar M, et al. Infant hearing loss and connexin testing in a diverse population. Genet Med. Jul 2008;10(7):517-24. [Medline].

  12. Korres S, Nikolopoulos TP, Komkotou V, et al. Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery. Otol Neurotol. Nov 2005;26(6):1186-90. [Medline].

  13. Northern JL, Downs MP. Hearing in Children. 4th ed. Baltimore, Md: Williams & Wilkins; 1991:28-31.

  14. Liu XZ, Angeli SI, Rajput K, et al. Cochlear implantation in individuals with Usher type 1 syndrome. Int J Pediatr Otorhinolaryngol. Jun 2008;72(6):841-7. [Medline].

  15. Van Laer L, Cryns K, Smith RJ, Van Camp G. Nonsyndromic hearing loss. Ear Hear. Aug 2003;24(4):275-88. [Medline].

  16. Nadol JB Jr, Merchant SN. Histopathology and molecular genetics of hearing loss in the human. Int J Pediatr Otorhinolaryngol. Oct 19 2001;61(1):1-15. [Medline].

  17. Arnos Kathleen. Ethical and social implications of genetic testing for communication disorders. Journal of Communication Disorders. September-October 2008;41:444-457.

  18. Anagnostakis D, Petmezakis J, Papazissis G, Messaritakis J, Matsaniotis N. Hearing loss in low-birth-weight infants. Am J Dis Child. Jul 1982;136(7):602-4. [Medline].

  19. Bergstrom L, Hemenway WG, Downs MP. A high risk registry to find congenital deafness. Otolaryngol Clin North Am. Jun 1971;4(2):369-99. [Medline].

  20. Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics. Mar 1999;103(3):546-50. [Medline].

  21. Cunningham M, Cox EO. Hearing assessment in infants and children: recommendations beyond neonatal screening. Pediatrics. Feb 2003;111(2):436-40. [Medline].

  22. Dahle AJ, McCollister FP, Hamner BA, Reynolds DW, Stagno S. Subclinical congenital cytomegalovirus infection and hearing impairment. J Speech Hear Disord. Aug 1974;39(3):320-9. [Medline].

  23. Davidson J, Hyde ML, Alberti PW. Epidemiologic patterns in childhood hearing loss: a review. Int J Pediatr Otorhinolaryngol. Jul 1989;17(3):239-66. [Medline].

  24. DeStefano AL, Gates GA, Heard-Costa N, Myers RH, Baldwin CT. Genomewide linkage analysis to presbycusis in the Framingham Heart Study. Arch Otolaryngol Head Neck Surg. Mar 2003;129(3):285-9. [Medline].

  25. Downs MP. Benefits of screening at birth: economic, educational and functional factors. In: NIH Consensus Development Conference. 1993:63-6.

  26. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics. Feb 1999;103(2):527-30. [Medline].

  27. Fraser GR. The Causes of Profound Deafness in Children. Baltimore, Md: Johns Hopkins University Press; 1976.

  28. Friedrick B. The state of art in audiologic evaluation and management. In: Cherow E, Matkin ND, Trybus RJ, eds. Hearing-Impaired Children and Youth with Developmental Disabilities: an Interdisciplinary Foundation for Service. Washington, DC: Gallaudet College Press; 1985:122-5.

  29. Gates GA, Couropmitree NN, Myers RH. Genetic associations in age-related hearing thresholds. Arch Otolaryngol Head Neck Surg. Jun 1999;125(6):654-9. [Medline].

  30. Jackler RK, Luxford WM, House WF. Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope. Mar 1987;97(3 Pt 2 Suppl 40):2-14. [Medline].

  31. Jackler RK, Luxford WM, House WF. Congenital malformations of the inner ear: a classification based on embryogenesis. Laryngoscope. Mar 1987;97(3 Pt 2 Suppl 40):2-14. [Medline].

  32. Kenna MA, Wu BL, Cotanche DA, Korf BR, Rehm HL. Connexin 26 studies in patients with sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. Sep 2001;127(9):1037-42. [Medline].

  33. Kenneson A, Van Naarden Braun K, Boyle C. GJB2 (connexin 26) variants and nonsyndromic sensorineural hearing loss: a HuGE review. Genet Med. Jul-Aug 2002;4(4):258-74. [Medline].

  34. Marlin S, Garabedian EN, Roger G, et al. Connexin 26 gene mutations in congenitally deaf children: pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg. Aug 2001;127(8):927-33. [Medline].

  35. Mauk GW, White KR, Mortensen LB, Behrens TR. The effectiveness of screening programs based on high-risk characteristics in early identification of hearing impairment. Ear Hear. Oct 1991;12(5):312-9. [Medline].

  36. Nance WE, Sweeney A. Symposium on sensorineural hearing loss in children: early detection and intervention. Genetic factors in deafness of early life. Otolaryngol Clin North Am. Feb 1975;8(1):19-48. [Medline].

  37. Northern JL. Impedance measurement in infants. In: Mencher GT, Gerber SE, eds. Early Management of Hearing Loss. New York, NY: Grune & Stratton; 1981:131-49.

  38. Northern JL. Universal screening for infant hearing impairment. Pediatrics. Dec 1994;94(6 Pt 1):955; author reply 959-63. [Medline].

  39. Northern JL, Hayes D. Universal screening for infant hearing impairment: necessary, beneficial and justifiable. Audiol Today. 1994;6:10-13.

  40. Paparella MM, Sugiura S, Hoshino T. Familial progressive sensorineural deafness. Arch Otolaryngol. Jul 1969;90(1):44-51. [Medline].

  41. Pass RF, Stagno S, Myers GJ, Alford CA. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics. Nov 1980;66(5):758-62. [Medline].

  42. Schuknecht HF. Pathology of the Ear. Philadelphia, Pa: Lea & Febiger; 1993.

  43. Skvorak Giersch AB, Morton CC. Genetic causes of nonsyndromic hearing loss. Curr Opin Pediatr. Dec 1999;11(6):551-7. [Medline].

  44. Smith Richard JH, Van Camp G. Deafness and Hereditary Hearing Loss, Overview. gene reviews. 2005;[Full Text].

  45. Smith Richard JH, Van Camp Guy. Deafness and Hereditary Hearing Loss Overview. geneReviews. Available at http://www.geneclinics.org/profiles/deafness-overview/details.html. Accessed December 22, 2008.

  46. Snoeckx RL, Huygen PL, Feldmann D, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Hum Genet. Dec 2005;77(6):945-57. [Medline].

  47. Stein L, Clark S, Kraus N. The hearing-impaired infant: patterns of identification and habilitation. Ear Hear. Sep-Oct 1983;4(5):232-6. [Medline].

  48. Stein LK, Jabaley T, Spitz R, Stoakley D, McGee T. The hearing-impaired infant: patterns of identification and habilitation revisited. Ear Hear. Jun 1990;11(3):201-5. [Medline].

  49. Tseng CJ, Lalwani AK. Cracking the auditory genetic code: part II. Syndromic hereditary hearing impairment. Am J Otol. May 2000;21(3):437-51. [Medline].

  50. Wilson J. Deafness in developing countries. Approaches to a global program of prevention. Arch Otolaryngol. Jan 1985;111(1):2-9. [Medline].

 
Previous
Next
 
Inner ear.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.